Table 1. Study characteristics of diabetic and non-diabetic pregnant women included in the study.
Authors | Year of publication | Country | Study Settings | Study design | BMI (Kg/m2) | Trimester of pregnancy | # Cases/controls | Sample | Level of AGEs (AU/mL) | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GDM | Controls | ||||||||||
Mean ±SD or Mean [95% CI] | Mean ±SD or Mean [95% CI] | ||||||||||
GDM | Controls | ||||||||||
Mean ±SD | Mean ±SD | ||||||||||
Aziz et al [37] | 2015 | Iraq | Hospitals in Baghdad | Case-control | 28.80±0.27 | 27.77±0.40 | Third | 30/30 | Blood | 5.29±0.28 | 2.76±0.33 |
Bartakova et al [30] | 2016 | Czek | Hospital of Brno | Case-control | 24.80 ± 1.76 | 21.15± 1.73 | Second | 182/36 | Blood | 10.18 [8.09–12.22] | 5.73 [5.29–8.66] |
Boutzios et al [31] | 2013 | Greece | Aretaieion University Hospital, Athens | Cross-sectional | 30.3 ± 4.4 | 27.9 ± 3.1 | Second | 54/56 | Blood | 7.28 ± 2.4 | 5.68 ± 1.3 |
Cosson et al [32] | 2019 | France | Jean-Verdier hospital, Paris | Case-control | NR | NR | Second | 48/70 | Skin | 1.99 ± 0.47 | 1.79 ± 0.32 |
First | 62/70 | 2.11 ± 0.48 | |||||||||
Davison et al [33] | 2011 | UK | Royal Liverpool University Hospital | Case-control | NR | NR | Third | 15/29 | Blood | 3.58±0.83 | 3.13±0.51 |
de Ranitiz-Greven et al [34] | 2012 | Netherlands | University Medical Center Utrecht | Cross sectional | 27.6 ± 6.0 | 25.0 ± 6.3 | Second | 60/44 | Skin | 1.73 ± 0.33 | 1.81± 0.30 |
Harsem et al [35] | 2008 | Norway | Ulleval University Hospital. | Case-control | 32.1 ± 4.33 | 28.5 ± 4.89 | Third | 34/38 | Blood | 1.72 (1.47–1.91) | 1.28 (1.13–1.42) |
Krishnasamy et al [39] | 2019a | India | Tertiary referral centers in Tamil Nadu | Case-control | 25.72 ± 5.48 | 24.22 ± 4.67 | Third | 50/50 | Blood | 13.18 ± 8.74 | 2.68 ± 0.89 |
Krishnasamy et al [40] | 2019b | India | Two tertiary care hospitals | Case-control | 26.36 ± 0.61 | 26.27 ± 0.25 | Third | 50/50 | Blood | 10.40 ± 0.98 | 4.71 ± 0.39 |
Li et al [41] | 2019 | China | Binzhou City Center Hospital | Case-control | 23.17±3.16 | 22.86±2.66 | Second | 72/80 | Placenta | 54.27±18.28 | 32.18±12.12 |
Li and Yang [42] | 2019 | China | Peking University First Hospital | Case-control | 22.71 ± 3.20 | 21.65 ± 2.84 | Second | 90/90 | Blood | 473.65 ± 105.32 | 324.36 ± 57.86 (ng/L)* |
Third | 90/90 | Blood | 533.47 ± 146.95 | 315.50 ± 77.79 (ng/L)* | |||||||
Lobo et al [44] | 2017 | Brazil | NS | Case-control | 32.0 ± 2.22 | 25.4 ± 1.48 | Second | 225/217 | Blood | 2.42 ± 0.72 | 2.50 ± 0.86 |
Pertyn´ska-Marczewska [36] | 2009 | Poland | Polish Mother’s Memorial Hospital | Case-control | 24.25 ± 2.57 | 23.17 ± 4.43 | First | 14/14 | Blood | 9.5 ± 1.9 | 5.2 ± 1.3 |
NR | NR | Third | 14/14 | Blood | 9.7 ± 1.9 | 5.3 ± 0.7 | |||||
Guosheng et al [38] | 2009 | China | First Affiliated Hospital of Jinan University | Case-control | NR | NR | Second | 60/72 | Blood | 8.114±2.375 | 4.262±1.284 |
Third | 72/80 | Blood | 8.085±2.396 | 4.830±1.156 | |||||||
Mai et al [43] | 2014 | China | Guangdong Women and Children Hospital | Case-control | 22.7±3.5 | 21.5±2.7 | NS | 190/80 | Blood | 403.0+ 208.6 | 321.8 +150.3 (ng/L) * |
Morales et al [45] | 2016 | Mexico | Regional general hospital | Cross-sectional | 33.99±5.32 | 30.09±4.02 | NS | 38/38 | Blood | NR | NR |
NS, not specified; NR, not recorded; SD, standardized difference
*measurements in units other than specified one. NB: Studies reported in 95% CI were converted to SD using STATA 15.0 for the sake of analysis.